MY152490A - New oral formulation - Google Patents

New oral formulation

Info

Publication number
MY152490A
MY152490A MYPI0304586A MY152490A MY 152490 A MY152490 A MY 152490A MY PI0304586 A MYPI0304586 A MY PI0304586A MY 152490 A MY152490 A MY 152490A
Authority
MY
Malaysia
Prior art keywords
oral formulation
new oral
composition
new
administering
Prior art date
Application number
Inventor
Karel De Bruijn
Gunter Engel
Hans-Jurgen Pfannkuche
Michael Thewissen
Christian Vitzling
Othmar Zuger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9818340.3A external-priority patent/GB9818340D0/en
Priority claimed from GBGB9910320.2A external-priority patent/GB9910320D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY152490A publication Critical patent/MY152490A/en

Links

Abstract

THE PRESENT INVENTION RELATES TO A PHARMACEUTICAL COMPOSITION, IN PARTICULAR TO A COMPOSITION FOR ADMINISTERING OF ACTIVE AGENTS WHICH ARE POORLY SOLUBLE IN AQUEOUS MEDIA, AND/OR WHICH ARE ACID SENSITIVE.
MYPI0304586 1998-08-21 1999-08-18 New oral formulation MY152490A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9818340.3A GB9818340D0 (en) 1998-08-21 1998-08-21 Organic compounds
GBGB9910320.2A GB9910320D0 (en) 1999-05-05 1999-05-05 Organic compounds

Publications (1)

Publication Number Publication Date
MY152490A true MY152490A (en) 2014-10-15

Family

ID=37001080

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI9903543 MY128958A (en) 1998-08-21 1999-08-18 New oral formulation for 5-ht4 agonists or antagonists.
MYPI0304586 MY152490A (en) 1998-08-21 1999-08-18 New oral formulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MYPI9903543 MY128958A (en) 1998-08-21 1999-08-18 New oral formulation for 5-ht4 agonists or antagonists.

Country Status (5)

Country Link
AR (2) AR018465A1 (en)
CO (1) CO5130010A1 (en)
MY (2) MY128958A (en)
PE (1) PE20000865A1 (en)
TW (1) TWI238725B (en)

Also Published As

Publication number Publication date
AR018465A1 (en) 2001-11-14
PE20000865A1 (en) 2000-09-07
MY128958A (en) 2007-03-30
TWI238725B (en) 2005-09-01
CO5130010A1 (en) 2002-02-27
AR030340A2 (en) 2003-08-20

Similar Documents

Publication Publication Date Title
YU8701A (en) New oral formulation
HUP0302086A2 (en) Oral pharmaceutical composition with a delayed action and process for its preparation
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
PL337794A1 (en) Pharmaceutic agent for oral administration containing an active substance and cyclodextrin
WO2000045800A3 (en) Immunosurpressive effects of pteridine derivatives
WO2000078294A3 (en) Oral administration form for administering a fixed tramadol and diclofenac combination
HK1045937A1 (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
GEP20043377B (en) Pharmaceutical Complex
AU5072000A (en) Pharmaceutical composition for nasally administering water-soluble active substances
HUP0200729A3 (en) Hydroxamic acid derivatives, their use and preparation and pharmaceutical compositions containing them
MY152490A (en) New oral formulation
TR200003451T2 (en) Pyrimidine-Aminomethyl-Pyridine Derivatives, Their Preparation and Their Use in the Control of Helicobacter Bacteria
HUP0200605A3 (en) Hydroxamic acid derivatives, their preparation and use and pharmaceutical compositions containing them
ECSP993104A (en) NEW ORAL FORMULATION
CR6300A (en) NEW ORAL FORMULATION
WO2001091733A3 (en) Combination of active substances containing montirelin and a compound having an opioid effect
YU87302A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1